title: Acquired perforating dermatosis associated with sorafenib therapy.
authors.affiliation: Department of Dermatology, Paul Sabatier University, Toulouse University Hospital, Toulouse, France.
authors.forename: M
authors.initials: M
authors.lastname: Severino-Freire
authors.affiliation: Departement of Dermatology, Institut Claudius Regaud, Toulouse, France.
authors.forename: V
authors.initials: V
authors.lastname: Sibaud
authors.affiliation: Department of Anatomo Pathology, Toulouse University Hospital, Toulouse, France.
authors.forename: E
authors.initials: E
authors.lastname: Tournier
authors.affiliation: Department of Dermatology, Paul Sabatier University, Toulouse University Hospital, Toulouse, France.
authors.forename: C
authors.initials: C
authors.lastname: Pauwels
authors.affiliation: Department of Hepatology, Toulouse University Hospital, Toulouse, France.
authors.forename: C
authors.initials: C
authors.lastname: Christol
authors.affiliation: Department of Anatomo Pathology, Toulouse University Hospital, Toulouse, France.
authors.forename: L
authors.initials: L
authors.lastname: Lamant
authors.affiliation: Department of Dermatology, Paul Sabatier University, Toulouse University Hospital, Toulouse, France.
authors.forename: J
authors.initials: J
authors.lastname: Hautier-Mazeereuw
authors.affiliation: Department of Hepatology, Toulouse University Hospital, Toulouse, France.
authors.forename: J-M
authors.initials: JM
authors.lastname: Peron
authors.affiliation: Department of Dermatology, Paul Sabatier University, Toulouse University Hospital, Toulouse, France.
authors.forename: C
authors.initials: C
authors.lastname: Paul
authors.affiliation: Department of Dermatology, Paul Sabatier University, Toulouse University Hospital, Toulouse, France.
authors.forename: C
authors.initials: C
authors.lastname: Bulai Livideanu
mesh_terms: D000287:Administration, Topical; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001706:Biopsy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000008:administration & dosage / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000008:administration & dosage*; D040262:Receptors, Vascular Endothelial Growth Factor; D012867:Skin / Q000473:pathology*; D012871:Skin Diseases / Q000188:drug therapy* / Q000473:pathology; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib; D040262:Receptors, Vascular Endothelial Growth Factor